Literature DB >> 24831932

Analysis of heart rate variability during auditory stimulation periods in patients with schizophrenia.

Saime Akdemir Akar1, Sadık Kara, Fatma Latifoğlu, Vedat Bilgiç.   

Abstract

The vulnerability-stress model is a hypothesis for symptom development in schizophrenia patients who are generally characterized by cardiac autonomic dysfunction. Therefore, measures of heart rate variability (HRV) have been widely used in schizophrenics for assessing altered cardiac autonomic regulations. The goal of this study was to analyze HRV of schizophrenia patients and healthy control subjects with exposure to auditory stimuli. More specifically, this study examines whether schizophrenia patients may exhibit distinctive time and frequency domain parameters of HRV from control subjects during at rest and auditory stimulation periods. Photoplethysmographic signals were used in the analysis of HRV. Nineteen schizophrenic patients and twenty healthy control subjects were examined during rest periods, while exposed to periods of white noise (WN) and relaxing music. Results indicate that HRV in patients was lower than that of control subjects indicating autonomic dysfunction throughout the entire experiment. In comparison with control subjects, patients with schizophrenia exhibited lower high-frequency power and a higher low-frequency to high-frequency ratio. Moreover, while WN stimulus decreased parasympathetic activity in healthy subjects, no significant changes in heart rate and frequency-domain HRV parameters were observed between the auditory stimulation and rest periods in schizophrenia patients. We can conclude that HRV can be used as a sensitive index of emotion-related sympathetic activity in schizophrenia patients.

Entities:  

Mesh:

Year:  2014        PMID: 24831932     DOI: 10.1007/s10877-014-9580-8

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  42 in total

1.  Comparison of pulse rate variability with heart rate variability during obstructive sleep apnea.

Authors:  Ahsan H Khandoker; Chandan K Karmakar; Marimuthu Palaniswami
Journal:  Med Eng Phys       Date:  2010-10-25       Impact factor: 2.242

2.  Cardiac risk and schizophrenia.

Authors:  Ripu Jindal; Erin M MacKenzie; Glen B Baker; Vikram K Yeragani
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

3.  Differential pattern of heart rate variability in patients with schizophrenia.

Authors:  Jae Seung Chang; Cheol Sung Yoo; Sang Hoon Yi; Kye Hyun Hong; Hong Seok Oh; Jae Youn Hwang; Su-Gyeong Kim; Yong Min Ahn; Yong Sik Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-05-07       Impact factor: 5.067

4.  Pulse rate variability compared with Heart Rate Variability in children with and without sleep disordered breathing.

Authors:  Parastoo Dehkordi; Ainara Garde; Walter Karlen; David Wensley; J Mark Ansermino; Guy A Dumont
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

5.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

Review 6.  Autonomic responses in psychiatric patients.

Authors:  R A Dykman; W G Reese; C R Galbrecht; P T Ackerman; R S Sundermann
Journal:  Ann N Y Acad Sci       Date:  1968-06-28       Impact factor: 5.691

7.  Altered performance of schizophrenia patients in an auditory detection and discrimination task: exploring the 'self-monitoring' model of hallucination.

Authors:  Chiang-shan Ray Li; Mon-chu Chen; Yong-yi Yang; Min-chi Chen; Pei-kwei Tsay
Journal:  Schizophr Res       Date:  2002-05-01       Impact factor: 4.939

8.  Comparison of AR and Welch methods in epileptic seizure detection.

Authors:  Ahmet Alkan; M Kemal Kiymik
Journal:  J Med Syst       Date:  2006-12       Impact factor: 4.460

9.  Computerized measurement of negative symptoms in schizophrenia.

Authors:  Alex S Cohen; Murray Alpert; Tasha M Nienow; Thomas J Dinzeo; Nancy M Docherty
Journal:  J Psychiatr Res       Date:  2007-10-24       Impact factor: 4.791

Review 10.  Schizophrenia.

Authors:  Kim T Mueser; Susan R McGurk
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

View more
  7 in total

1.  Combining electroencephalographic activity and instantaneous heart rate for assessing brain-heart dynamics during visual emotional elicitation in healthy subjects.

Authors:  G Valenza; A Greco; C Gentili; A Lanata; L Sebastiani; D Menicucci; A Gemignani; E P Scilingo
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-05-13       Impact factor: 4.226

2.  Aberrant parasympathetic reactivity to acute psychosocial stress in male patients with schizophrenia spectrum disorders.

Authors:  Elizabeth H Andersen; Gregory F Lewis; Aysenil Belger
Journal:  Psychiatry Res       Date:  2018-04-06       Impact factor: 3.222

3.  Early Signs of Schizophrenia and Autonomic Nervous System Dysregulation: A Literature Review.

Authors:  Camilla Guccione; Giulia Lanza di Scalea; Marianna Ambrosecchia; Grazia Terrone; Gianluigi Di Cesare; Giuseppe Ducci; Adriano Schimmenti; Vincenzo Caretti
Journal:  Clin Neuropsychiatry       Date:  2019-04

Review 4.  Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis.

Authors:  Gail A Alvares; Daniel S Quintana; Ian B Hickie; Adam J Guastella
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

Review 5.  Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health.

Authors:  Margaret K Hahn; Sri Mahavir Agarwal; Nicolette Stogios; Alexander Gdanski; Philip Gerretsen; Araba F Chintoh; Ariel Graff-Guerrero; Tarek K Rajji; Gary Remington
Journal:  NPJ Schizophr       Date:  2021-04-26

6.  Resting Heart Rate and Auditory Evoked Potential.

Authors:  Simone Fiuza Regaçone; Daiane Damaris Baptista de Lima; Vitor Engrácia Valenti; Ana Cláudia Figueiredo Frizzo
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

7.  Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy.

Authors:  Misako Kanayama; Tsuyoshi Miyaoka; Tomoko Araki; Maiko Hayashida; Sadayuki Hashioka; Jun Horiguchi
Journal:  Case Rep Psychiatry       Date:  2018-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.